Multicentric European Study In Patients With Vertebral Metastases
NCT ID: NCT06220071
Last Updated: 2025-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
356 participants
OBSERVATIONAL
2024-02-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This type of dataset is not currently available in the literature and it will be pivotal to the development of the METASTRA computational models for the stratification of the risk of fracture of patients affected by spinal metastases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Metastases in Norway - A Prospective Cohort Study
NCT03346655
Local Radiotherapy Following Complete Resection of a Brain Metastasis
NCT02729558
Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases
NCT02265549
SPT Screening in Irradiated Hereditary Retinoblastoma Survivors
NCT02329002
WHOle Brain Irradiation or STEreotactic Radiosurgery for Five or More Brain Metastases (WHOBI-STER)
NCT04891471
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vertebral metastases
Patients affected by spinal metastases that are not surgically treated
Case series review of clinical and radiographic data
Extraction of clinical and radiographic data related to patients' history from medical records
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Case series review of clinical and radiographic data
Extraction of clinical and radiographic data related to patients' history from medical records
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 -99 years old
* Both male and female
* Diagnosis of cancer metastases at the spine
* Any SINS score
* Admitted for hospitalisation or outpatient visit from Jan 2012 to Dec 2022 N ≥ 1 non-stabilised metastatic vertebra
* Presence of baseline CT scan, and/or MRI and x-rays, showing the presence of metastatic lesions that are not surgically treated
* At least one follow-up visit at ≥ 3 months after the first evaluation or treatment
Exclusion Criteria
* Patients with diagnosis of primary spine tumour, degenerative spinal diseases, deformity or trauma
* Patients without non-stabilised vertebral metastases
* Patients without baseline CT scan or MRI
* Patients without follow up visits
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Ortopedico Rizzoli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite - Universitaetsmedizin Berlin
Berlin, , Germany
Budai Egeszsegkozpont Zrt
Budapest, , Hungary
Universitair Medisch Centrum Utrecht
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Train-METASTRA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.